Variant report
Variant | esv2608601 |
---|---|
Chromosome Location | chr3:48251783-48256238 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:48255769..48258567-chr3:48261037..48262599,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559788036 | chr3:48251789-48251790 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530074763 | chr3:48251834-48251835 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549274468 | chr3:48251867-48251868 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560996547 | chr3:48251877-48251878 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574187231 | chr3:48251878-48251879 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531560869 | chr3:48251943-48251944 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192510652 | chr3:48251958-48251959 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144066916 | chr3:48252000-48252001 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200697769 | chr3:48252051-48252052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547052411 | chr3:48252121-48252122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9832529 | chr3:48252176-48252177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9869759 | chr3:48252183-48252184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9832262 | chr3:48252184-48252185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372943314 | chr3:48252327-48252328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375623838 | chr3:48252460-48252461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370219664 | chr3:48252638-48252639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374433940 | chr3:48252733-48252734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377518445 | chr3:48252916-48252917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7643776 | chr3:48252993-48252994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371223978 | chr3:48253113-48253114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7621097 | chr3:48253152-48253153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7643958 | chr3:48253184-48253185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7621275 | chr3:48253287-48253288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7644057 | chr3:48253332-48253333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7623556 | chr3:48253409-48253410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7623644 | chr3:48253466-48253467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7623649 | chr3:48253484-48253485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368355912 | chr3:48253663-48253664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371927023 | chr3:48253668-48253669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528362060 | chr3:48253674-48253675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548536526 | chr3:48253687-48253688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368425177 | chr3:48253716-48253717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568237313 | chr3:48253757-48253758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7616238 | chr3:48253812-48253813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7623962 | chr3:48253819-48253820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6772529 | chr3:48254580-48254581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6769926 | chr3:48254599-48254600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6772766 | chr3:48254799-48254800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371882435 | chr3:48254833-48254834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111863406 | chr3:48254902-48254903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112302784 | chr3:48254903-48254904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78141350 | chr3:48254996-48254997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375675577 | chr3:48254997-48254998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565354243 | chr3:48255026-48255027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551627294 | chr3:48255093-48255094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535819779 | chr3:48255148-48255149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553951441 | chr3:48255183-48255184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11715799 | chr3:48255220-48255221 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs576647720 | chr3:48255233-48255234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537692830 | chr3:48255246-48255247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
abnormal development | 18461090 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:48248400-48255800 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr3:48250800-48251800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:48251000-48252000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr3:48251200-48256400 | Weak transcription | Lung | lung |
5 | chr3:48251600-48251800 | Enhancers | HepG2 | liver |
6 | chr3:48251600-48255800 | Weak transcription | Spleen | Spleen |
7 | chr3:48251800-48255000 | Weak transcription | HepG2 | liver |
8 | chr3:48251800-48264800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr3:48255000-48256400 | Enhancers | HepG2 | liver |
10 | chr3:48255800-48256000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr3:48255800-48256000 | Enhancers | Stomach Smooth Muscle | stomach |
12 | chr3:48255800-48258200 | Enhancers | Gastric | stomach |
13 | chr3:48255800-48258400 | Enhancers | Right Atrium | heart |
14 | chr3:48255800-48259400 | Enhancers | Pancreas | Pancrea |
15 | chr3:48255800-48260000 | Enhancers | Spleen | Spleen |
16 | chr3:48255800-48261600 | Enhancers | Adipose Nuclei | Adipose |
17 | chr3:48256000-48256400 | Weak transcription | Stomach Smooth Muscle | stomach |
18 | chr3:48256000-48256800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr3:48256000-48258400 | Enhancers | Fetal Lung | lung |
20 | chr3:48256200-48258000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr3:48256200-48258000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
22 | chr3:48256200-48258200 | Enhancers | Left Ventricle | heart |
23 | chr3:48256200-48261600 | Enhancers | Ovary | ovary |